
Gabe Friedman Gabe Friedman is the Jewish Telegraphic Agency’s (JTA) Deputy Managing Editor. He was previously JTA’s Associate Editor for Digital. Prior to joining JTA, Gabe was an arts and culture fellow at the Forward. Gabe has also been published in The New York Times, Pitchfork, and the Village Voice, and he is a graduate of the University of Chicago. https://twitter.com/gabefriedman563
(JTA) — NOVEMBER 31, 2020 — As the American drug company Moderna announced Monday that it had developed a COVID-19 vaccine that is 94.5% effective, Israeli scientist Tal Zaks was among the company leaders touting the good news to the media.
That’s because Zaks, who earned a doctorate at Ben-Gurion University in Beersheba, is the chief medical officer at Moderna and has been involved in overseeing its unprecedentedly rapid push for a coronavirus vaccine.
“The overall effectiveness has been remarkable … it’s a great day,” he told BBC News.
In an interview last month with The Jerusalem Post, Zaks said he moved to the United States because it offered him a greater chance to “fulfill my dream and translate science into medicine.”
“I hope that Israel will continue to develop its bio-tech sector. Wherever I can be most effective is where you’ll find me,” the 54-year-old scientist said.